Expression of Cyclooxygenase-2 and Its Correlation with Vasogenic Brain Edema in Human Intracranial Meningiomas

REFERENCES

• Perry A., Statford S. L., Scheithauer B. W., Suman V. J., Lohse C. M., Wollan P. C. “Malignancy” in meningiomas: a clinicopathologic study of 116 patients. Cancer 1999; 85: 2046–2056
   PubMed Web of Science ®Google Scholar
• Watson M. A., Gutmann D. H., Peterson K., Chicoine M. R., Kleinschmidt-DeMasters B. K., Brown H. G., Perry A. Molecular characterization of human meningiomas by gne expression profilino using high-density oligonucleotide microarrays. AJP 2002; 161: 665–672
   Web of Science ®Google Scholar
• Pistolesi S., Boldrini L., Gisfredi S., De Ieso K., Camacci T, Caniglia M., Lupi G., Leocata P., Basolo F., Pingitore R., Parenti G., Fontanini G. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study. Neuropathology and Applied neurobiology 2004; 30: 118–125
   PubMed Web of Science ®Google Scholar
• Provias J., De Claffey K. I., Aguila L., Nelson L., Feldkamp M., Guha A. Meningiomas: role of vascular endothelial growth factor/vascular permeabilità factor in angiogenesis and peritumoral edema. Neurosurgery 1997; 40: 1016–1026
   PubMed Web of Science ®Google Scholar
• Pistolesi S., Fontanini G., Boldrini L., Camacci T., De Ieso K., Lupi G., Caniglia M., Mariani G., Boni G., Suriano S., Padolecchia R., Pingitore R., Parenti G. The role of somatostatin in vasogenic meningioma associated brain edema. Tumori 2003; 89: 136–140
   PubMed Web of Science ®Google Scholar
• Assimakopoulou M., Sotiropoulou-Bonikou G., Maraziotis T., Papadakis N., Varakis I. Microvessel density in brain tumours. Anticancer Res. 1997; 17: 4747–4753
   PubMed Web of Science ®Google Scholar
• Hanahan D., Folkman J. Patterns and emergine mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353–364
   PubMed Web of Science ®Google Scholar
• Tsai J. C., Hsiao Y. Y., Teng L. J., Shun C. T., Goldman C. K., Kao M. C. Regulation of vascular endothelial growth factor secretion in human menigioma cells. J. Formos. Med. Assoc. 1999; 98: 111–117
   PubMed Web of Science ®Google Scholar
• Bohuslavizki K. H., Brenner W., Braunsdorf W. E., Behnke A., Tinnermayer S., Hugo H. H., Jahn N., Wolf H., Sippel C., Clausen M., Mehdorn H. M., Henze E. Somatostain receptor scintigraphy in the differentil diagnosis of meningioma. Nucl. Med. Commun. 1996; 17: 302–310
   PubMedGoogle Scholar
• Nathoo N., Barnett G. H., Golubic M. The eicosanoid cascade: possible role in gliomas and meningiomas. J. Clin. Pathol. 2004; 57: 6–13
   PubMed Web of Science ®Google Scholar
• Lin C. C., Kenyon L., Hyslop T., Hammond E., Andrews D. W., Curran W. J., Jr., Dicker A. P. Cyclooxygenase-2 (COX-2) expression in human meningiomas as a function of tumor grade. Am. J. Clin. Oncol. 2003; 26: 98–102
   PubMedGoogle Scholar
• Joki T., Heese O., Nikas D. C., Bello L., Zhang J., Kraeft S. K., Seyfried N. T., Abe T., Chen L. B., Carroll R. S., Black P. M. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res. 2000; 60: 4296–4931
   Google Scholar
• Deininger M. H., Meyermann R., Trautmann K., Morgalla M., Duffner F., Grote E. H., Wickboldt J., Schluesener H. J. Cyclooxygenase (COX)-1 expressing macrophages/microglial cells and COX-2 expressing astrocytes accumulate during oligodendroglioma progression. Brain Res. 2000; 885: 111–116
   PubMed Web of Science ®Google Scholar
• Smith W. L., Garavito M., DeWitt D. L. Prostaglandin endoperoxide H synthase (cyclooxygenase)-1 and 2. J. Biol. Chem. 1996; 271: 33157–33160
   PubMed Web of Science ®Google Scholar
• Pairet M., Engelhardt G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implication. Fundam. Clin. Pharmacol. 1996; 10: 1–17
   PubMed Web of Science ®Google Scholar
• DuBois R. N., Awad J., Morrow J., Roberts L. J., II, Bishop P. R. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Investig. 1994; 93: 493–498
   PubMed Web of Science ®Google Scholar
• Iadecola C., Forster C., Nogawa S., Clark H. B., Ross M. E. Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia. Acta. Neuropathol. Berl. 1999; 98: 9–14
   PubMed Web of Science ®Google Scholar
• Ellis E. F., Chao J., Heizer M. L. Brain kininogen following experimental brain injury: evidence for a secondary event. J. Neurosurg. 1989; 71: 437–442
   PubMed Web of Science ®Google Scholar
• Bagetta G., Corasaniti M. T., Paoletti A. M., Berliocchi L., Nistico R., Giammarioli A. M., Malorni W. Finazzi-Agro, A. HIV-1 gp120-induced apoptosis in the rat neocortex involves enhanced expression of cycloxygenase type 2 (COX-2). Biochem. Biophys. Res. Commun. 1998; 244: 818–824
   Google Scholar
• Lukiw W. J., Bazan N. G. Cycloxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex. J. Neurosi. Res. 1997; 50: 937–945
   PubMed Web of Science ®Google Scholar
• Zimmermann K. C., Sarbia M., Weber A. A., Borchard F., Gabbert H. E. Schrork, Cycloxygenase-2 expression in human esophageal carcinoma. Cancer Res. 1999; 59: 198–204
   PubMed Web of Science ®Google Scholar
• Molina M. A., Sitja A., Lemoine M. G., Frazier M. L., Sinicrope F. A. Increased Cycloxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res. 1999; 59: 4356–4362
   PubMed Web of Science ®Google Scholar
• Wardlaw S. A., March T. H., Belinsky S. A. Cycloxygenase-2 expression is abundante in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions. Carcinogenesis (Lond) 2000; 21: 1371–1377
   PubMed Web of Science ®Google Scholar
• Yip-Schneider M. T., Barnard D. S., Billings S. D., Cheng L., Heilman D. K., Lin A., Marshall S. J., Crowell P. L., Marshall M. S., Sweeney C. J. Cycloxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis (Lond) 2000; 21: 139–136
   PubMed Web of Science ®Google Scholar
• Yoshimura R., Sano H., Masuda C., Kawamura M., Tsubouchi Y., Chargui J., Yoshimura N., Hla T., Wada S. Expression of Cycloxygenase-2 in prostate carcinoma. Cancer (Phila) 2000; 89: 589–596
   PubMed Web of Science ®Google Scholar
• Kargman S. L., O'Neill G. P., Vickers P. J., Evans J. F., Mancini J. A., Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 1995; 55: 2556–2559
   PubMed Web of Science ®Google Scholar
• Kutchera W., Jones D. A., Matsunami N., Groden J., McIntyre T. M., Zimmermann G. A., White R. L., Prescott S. M. Prostaglandin Hsynthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA 1996; 93: 4816–4820
   PubMed Web of Science ®Google Scholar
• Chan G., Boyle J. O., Yang E. K., Zhang F., Sacks P. G., Shah J. P., Edelstein D., Soslow R. A., Koki A. T., Woerner B. M., Masferrer J. L., Dannenberg A. J. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res. 1999; 59: 991–994
   PubMed Web of Science ®Google Scholar
• Hida T., Yatabe Y., Achiwa H., Muramatsu H., Kozaki K., Nakamura S., Ogawa M., Mitsudomi T., Sugiura T., Takahashi T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res. 1998; 58: 3761–3764
   PubMed Web of Science ®Google Scholar
• Paoletti P., Chiabrando C., Gaetani P., Castelli M. G., Butti G., Martelli L., Rolli M. Prostaglandins in human brain tumors. J. Neurosurg. 1989; 33: 65–69
   Google Scholar
• Subbaramaiah K., Telang N., Ramonetti J. T., Araki R., De Vito B., Weksler B. B., Dannenberg A. J. Transcription of cyclooxygenase-2 is enhanced in trasformed mammary epithelial cells. Cancer Res. 1996; 56: 4424–4429
   PubMed Web of Science ®Google Scholar
• Shono T., Tofilon P. J., Bruner J. M., Owolabi O., Lang F. F. Cyclooxygenase-2 expression in human gliomas. Prognostic significance and molecular correlation. Cancer Res. 2001; 61: 4375–4381
   Web of Science ®Google Scholar
• Eberhart C. E., Coffey R. J., Radhika A., Giardiello F. M., Ferrenbach S. DuBois R. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183–1188
   Google Scholar
• Sano H., Kawahito Y., Wilder R. L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M. T. Transcription of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 1995; 55: 3785–3789
   PubMed Web of Science ®Google Scholar
• Kune G. A., Kune S., Watson L. F. Colorectal cancer risk, chronic illness, operations and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res. 1988; 48: 4399–4404
   PubMed Web of Science ®Google Scholar
• Thun M. J., Namboodiri M. M., Heat C. W. Jr. Aspirin use and reduced risk of fatal colorectal cancer. N. Engl. J. Med. 1991; 325: 1593–1596
   Google Scholar
• Jacoby R. F., Seibert K., Cole C. E., Kelloff G., Lubet R. A. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res. 2000; 60: 5040–5044
   PubMed Web of Science ®Google Scholar
• Tsujii M., Kawano S., Tsujii S., Sawaoka H., Hori M., DuBois R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93: 705–716
   PubMed Web of Science ®Google Scholar
• Liu X. H., Kirschenbaum A., Yao S., Stearns M. E., Holland J. F., Claffey K., Levine A. C. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin. Exp. Metastasis 1999; 17: 687–694
   PubMed Web of Science ®Google Scholar
• Liu X. H., Kirschenbaum A., Yao S., Lee R., Holland J. F., Levine A. C. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J. Urol. 2000; 164: 820–825
   PubMed Web of Science ®Google Scholar
• Attiga F. A., Fernandez P. M., Weeraratna A. T., Manyak M. J., Paterno S. R. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res. 2000; 60: 4629–4637
   PubMed Web of Science ®Google Scholar
• Tsujii M., DuBois R. N. Alteration in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83: 493–501
   PubMed Web of Science ®Google Scholar
• Subbaramaiah K., Altorki N., Chung W. J., Mestre J. R., Sampat A., Dannenberg A. J. Inhibition of cyclooxygenase-2 gene expression by p53. J. Biol. Chem. 1999; 274: 10911–10915
   PubMed Web of Science ®Google Scholar
• Lamberts S. W.J., Krenning E. P., Reubi J. C. The role of somatostatin and its analogs in the diagnosis and treatment of tumours. Endocr. Rev 1991; 12: 450–482
   PubMed Web of Science ®Google Scholar
• Bitzer M., Wockel L., Luft A. R., Wakhloo A. K., Petersen D., Opitz H., Sievert T., Ernemann U., Voigt K. The importance of pial blood supply to the development of peritumoural brain oedema in meningiomas. J. Neurosurg. 1997; 87: 368–373
   PubMed Web of Science ®Google Scholar
• Pistolesi S., Fontanini G., Camacci T., De Ieso K., Boldrini L., Lupi G., Padolecchia R., Pingitore R., Parenti G. Meningioma-associated brain oedema: the role of angiogenic factors and pial blood supply. J. Neuro-Oncol. 2002; 60: 159–164
   PubMed Web of Science ®Google Scholar
• Kleihues P., Louis D. N., Scheithauer B. W., Rorke L. B., Reifenberger G., Burger P. C., Cavanee W. K. The WHO classification of tumors of the nervous system: J. Neuropathol. Exp. Neurol. 2002; 61: 215–225
   PubMed Web of Science ®Google Scholar
• Taketo M. M. Cyclooxigenase-2 inhibitors in tumorigenesis (part I). J. Natl. Cancer Inst. (Bethesda) 1998; 90: 1529–1536
   PubMed Web of Science ®Google Scholar
• Giardiello F. M., Hamilton S. R., Krush A. J., Piantadosi S., Hylind L. M., Celano P., Booker S. V., Robinson C. R., Offerhaus G. J. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med. 1993; 328: 1313–1316
   PubMed Web of Science ®Google Scholar
• Kune G. A., Kune S., Watson L. F. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the melbourne Colorectal Cancer Study. Cancer Res. 1988; 48: 4399–4404
   PubMed Web of Science ®Google Scholar
• Thun M. J., Namboodiri M. M., Heath C. W. Jr. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 1991; 325: 1593–1596
   Google Scholar
• Castelli M. G., Chiabrando C., Fanelli R., Martelli L., Butti G., Gaetani P., Paoletti P. Increased Prostaglandin and thromboxane synthesis by human intracranial tumors. Cancer Res 1989; 49: 1505–1508
   PubMed Web of Science ®Google Scholar
• Joki T., Heese O., Nikas D. C., Bello L., Zhang J., Kraeft S. K., Seyfried N. T., Abe T., Chen L. B., Carroll R. S., Black P. M. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res. 2000; 98: 240–244
   Google Scholar
• Matsuo M., Yonemitsu N., Zaitsu M., Ishii K., Hamasaki Y., Fukuyama K., Tabuchi K., Miyazaki S. Expression of prostaglandin H synthase-2 in human brain tumors. Acta. Neuropathol. (Berl) 2001; 102: 181–187
   PubMed Web of Science ®Google Scholar
• Ragel B. T., Jensen R. L., Gillespie D. L., Prescott S. M., Couldwell W. T. Ubiquitous expression of cyclooxigenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. J. Neurosurg. 2005; 103: 508–517
   PubMed Web of Science ®Google Scholar
• Boldrini L., Pistolesi S., Gisfredi S., Ursino S., Lupi G., Caniglia M., Pingitore R., Basolo F., Parenti G., Fontanini G. Telomerase in intracranial meningiomas. Int. J. Mol. Med. 2003; 12: 943–947
   PubMed Web of Science ®Google Scholar
• Khan R. B., Krasin M. J., Kasow K., Leung W. Cyclooxygenase-2 inhibition to treat radiation-induced brain necrosis and edema. J. Pediatr. Hematol. Oncol. 2004; 26: 253–255
   PubMed Web of Science ®Google Scholar